Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against COVID-19

Jul 03, 2021

Hyderabad (Telangana) [India], July 3 : Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial...

Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin

Nov 27, 2020

Ahmedabad (Gujarat) [India], November 27 : The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with five volunteers at Sola Civil Hospital in Ahmedabad...

DCGI likely to approve phase 3 trial data of Covaxin on Tuesday

Jun 22, 2021

New Delhi [India], June 22 : The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin...

COVID-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur from October

Sep 25, 2020

Lucknow (Uttar Pradesh) [India], September 25 : The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start...

Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat Biotech

Mar 03, 2021

Hyderabad (Telangana) [India], March 3 : Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the...

COVAXIN phase 3 full trial data will be made public in July: Bharat Biotech

Jun 09, 2021

New Delhi [India], June 9 : Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in...